ArticleActa gastroenterologica Latinoamericana
[Hereditary Hemochromatosis].
Article in Acta gastroenterologica Latinoamericana. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 1 paper.
What it found
Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.
The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.
The trial behind it
Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.
Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.
Who cites it
1 citing paper in PubMed.
- A decade of iron overload disorders and hemochromatosis: clinical and genetic findings from a specialized center in Colombia.Frontiers in medicine · 2024Article
Corrections and comments
PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.
Authors and funding
2 authors.
Funding
No grant is acknowledged in the PubMed record.
Abstract
Hereditary or genetic hemochromatosis is a group of disorders in which different mutations lead to iron overload affecting different organs and systems. This disease left to its natural history can cause cirrhosis, hepatocarcinoma, diabetes mellitus and arthropathies, among other pathologies. The involvement of one or more components of the hepcidin-ferroportin axis of the iron metabolism system is the common denominator of the different types of hereditary hemochromatosis. The HFE C282Y gene mutation is the most frequently detected mutation in Northern European patients and offspring. Diagnosis is based on the biochemical phenotype, magnetic resonance imaging showing hepatic iron overload and detection of the HFE C282Y mutation, in the absence of other comorbidities. However, in South America, the HFE C282Y gene mutation is rare, which changes the algorithm for diagnosing the disease. The treatments of choice, which can reverse the involvement of organs affected by iron overload, are phlebotomies or erythropheresis.
Indexed as
Identifiers
What OpenQuestion holds
Registered trials
Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.